Metraipolis › archive › dc_ff5992b623da

IGSF11-Mediated Immune Modulation: Unlocking a Novel Pathway in Emerging Cancer Immunotherapies — Europe PMC PMID:40867265

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40867265
DOI: 10.3390/cancers17162636
License (as archived): solo-consultazione
Archived: 2026-11-10T15:37:20.362Z
SHA-256 of the archived text: 9b56ff8318d94cdd6a7ea9357ea66cb5561715d27f9704998deea93e1500f767
Stable URL of this page: https://metraipolis.com/documento/dc_ff5992b623da

How to cite

IGSF11-Mediated Immune Modulation: Unlocking a Novel Pathway in Emerging Cancer Immunotherapies — Europe PMC PMID:40867265 — Europe PMC (en), https://europepmc.org/article/MED/40867265 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff5992b623da (Metraipolis archive dc_ff5992b623da, sha256 9b56ff8318d94cdd6a7ea9357ea66cb5561715d27f9704998deea93e1500f767)

BibTeX

@misc{dcff5992b623da,
  title = {IGSF11-Mediated Immune Modulation: Unlocking a Novel Pathway in Emerging Cancer Immunotherapies — Europe PMC PMID:40867265},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40867265},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff5992b623da; sha256 9b56ff8318d94cdd6a7ea9357ea66cb5561715d27f9704998deea93e1500f767},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40867265. Agents can read the archived copy with the MCP tool read_document.